Healthcare >> CEO Interviews >> September 13, 2002
FRANK HOLLER, President & CEO of Xenon Genetics, is a well-known
Biotechnology Executive. Prior to joining Xenon in February 1999, Mr.
Holler was President & CEO and a co-Founder of ID Biomedical
Corporation, as well as a Founding Director of Angiotech
Pharmaceuticals. Mr. Holler is also Chairman of BIRC Corporation, a
Vancouver-based government funded venture capital company, a Director of
analytical services company CanTest, and a Director of Cromedica Prime,
a Phase 1 clinical trials company located in British Columbia. Prior to
working in biotechnology and healthcare, Mr. Holler was an investment
banker with Merrill Lynch Canada and CIBC World Markets. He holds
degrees in economics (BA - 1981) and business administration (MBA -
1984) from the University of British Columbia. Profile
see the company today?
Mr. Holler: Xenon Genetics is a private genomics-based drug discovery
company. We're focused in
